Sphere Fluidics’ Blogs

10 years since the launch of Sphere Fluidics

Professor Chris Abell talks about developing Cyto-Mine®, and novel applications of droplet-based microfluidic technology

Accelerating Therapeutic Discovery and Regenerative Medicine

Professor Matthew Dalby explores accelerating and improving therapeutic discovery and regenerative medicine by inspiring the next generation of talent.

Use of picodroplets improves early cancer cell detection

Professor Wilhelm Huck discusses the application of single cell analysis in diagnostics and his work using droplet-based microfluidics to detect CTCs.

How can we speed up vaccine development for COVID-19?

Our CEO, Dr Frank Craig, discusses how Cyto-Mine® reduces the cell line development process by 3 months, enabling researchers to make a new vaccine much faster

4 Best practices for optimizing Cell Line Development processes

Dr Jon Dempsey, Pathway Biopharma, explores how companies can improve product quality and yields, as well as shorten overall cell line development timelines.

Transforming Cell Line Development Processes

Dr Fay Saunders shares her experience of using Cyto-Mine® in cell line development and recombinant protein expression at FUJIFILM Diosynth Biotechnologies.

Sorting and optimizing PMT settings using Cyto-Mine®

This article outlines some techniques and tips on optimizing PMT settings for sorting and dispensing using Cyto-Mine®.

Why Make the Switch to Picodroplet-based Technologies for Antibody Discovery?

Learn more about the benefits of switching to picodroplet-based technologies for antibody discovery.

The Sphere Fluidics' SAB: Insights from Dr Tristan Vaughan

Dr Tristan Vaughan shares his perspectives on biological medicines development and the potential of single cell analysis platforms.

Targeting Antigen Specificity: A Revolutionary Platform for Isolating Rare Cells

Learn how the use of picodroplets increases the speed and efficiency of selective cell screening and reduces screening costs.